Edwards Lifesciences (EW) Net Margin Growth (1y) (2010 - 2025)
Edwards Lifesciences (EW) Net Margin Growth (1y) (2010 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 129.62 Bn | 126.15 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 119.89 Bn | 110.67 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 74.01 Bn | 73.47 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 52.48 Bn | 48.23 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 34.64 Bn | 32.69 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 67.00 |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | 178.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -112.00 |
| Sep 30, 2025 | -20,002.00 |
| Jun 30, 2025 | -36.00 |
| Mar 31, 2025 | -247.00 |
| Dec 31, 2024 | -5.00 |
| Sep 30, 2024 | 19,596.00 |
| Jun 30, 2024 | -416.00 |
| Mar 31, 2024 | -2,592.00 |
| Dec 31, 2023 | -8,978.00 |
| Sep 30, 2023 | -2,212.00 |
| Jun 30, 2023 | -2,535.00 |
| Mar 31, 2023 | 2.00 |
| Dec 31, 2022 | 6,746.00 |
| Sep 30, 2022 | 8.00 |
| Jun 30, 2022 | -599.00 |
| Mar 31, 2022 | 6.00 |
| Dec 31, 2021 | -76.00 |
| Sep 30, 2021 | -255.00 |
| Jun 30, 2021 | 4,875.00 |
| Mar 31, 2021 | 28.00 |